ID: h-91bdb9ad
Hypothesis
Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy
Small molecule activators of Miro1 GTPase activity increase mitochondrial motility and facilitate intercellular transfer through enhanced organelle mobilization, targeting fundamental transport machinery.
EvidencePending (0%)📖 16 cit🗣 3 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Small molecule activators of Miro1 GTPase activity increase mitochondrial motility and facilitate intercellular transfer through enhanced organelle mobilization, targeting fundamental transport machinery.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
graph TD
A["Miro1/RHOT1 Gene"] --> B["Miro1 GTPase on Outer Mitochondrial Membrane"]
B --> C["Milton/TRAK Adaptor Binding"]
C --> D["Kinesin Motor Complex"]
C --> E["Dynein Motor Complex"]
D --> F["Anterograde Transport"]
E --> G["Retrograde Transport"]
F --> H["Mitochondria to Synaptic Terminals"]
G --> I["Damaged Mitochondria to Soma"]
J["Neurodegeneration"] --> K["Miro1 Dysfunction"]
K --> L["Impaired Mitochondrial Trafficking"]
L --> M["Synaptic Energy Deficit"]
L --> N["Failed Mitophagy"]
M --> O["Synaptic Dysfunction"]
N --> P["Damaged Mito Accumulation"]
P --> Q["Oxidative Stress"]
R["Miro1 Enhancement Therapy"] --> S["Restore Miro1-TRAK Interaction"]
S --> T["Normalize Anterograde Transport"]
S --> U["Restore Retrograde Transport"]
T --> V["Synaptic Mitochondrial Supply"]
U --> W["Efficient Damaged Mito Clearance"]
V --> X["Restored Synaptic ATP"]
W --> Y["Reduced ROS"]
X --> Z["Neuroprotection"]
Y --> Z
style J fill:#4a1942,stroke:#ce93d8,color:#e0e0e0
style R fill:#1a3a4a,stroke:#4fc3f7,color:#e0e0e0
style V fill:#1a3a2a,stroke:#81c784,color:#e0e0e0
style Z fill:#2a3a1a,stroke:#c5e1a5,color:#e0e0e0⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Supports
Miro1 controls mitochondrial transport and is essential for intercellular mitochondrial transfer
Supports
Enhanced Miro1 activity promotes mitochondrial rescue in cellular stress models
Contradicts
Miro1 overexpression causes mitochondrial transport defects and cellular stress in neurons
Contradicts
Parkinson's disease involves Miro1 degradation as a protective mechanism to prevent damaged mitochondrial spread
Contradicts
Enhanced mitochondrial motility can increase oxidative stress by disrupting mitochondrial networks
📖 Linked Papers (15)Export BibTeX ↗
Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss.
Brain : a journal of neurology (2025) · PubMed:39913247 ↗
6 figures

Figure 1
Parkinson's disease-related pathways were deregulated in p.R272Q Miro1 mutant midbrain organoids and dopaminergic neurons. ( A ) Schematic representation of th...

Figure 2
p.R272Q Miro1 mutation increased ROS and impaired mitochondrial membrane potential in vitro . ( A ) Flow cytometry representation ( left ) and quantification ...
Harlequin syndrome associated with thoracic epidural anaesthesia.
Anaesthesia reports (2022) · PubMed:35118419 ↗
1 figure
Figures
Figures available at source paper (no open-access XML found).
Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan.
Scientific reports (2021) · PubMed:34285270 ↗
8 figures

Figure 1
Minimum inhibitory concentration of vancomycin and teicoplanin for vancomycin-resistant Enterococcus faecium isolates during the outbreak. According to the cr...

Figure 2
Dendrogram of pulsotypes in pulsed-field gel electrophoresis and sequence types in multilocus sequence typing among vancomycin-resistant Enterococcus faecium ...
High resolution spatiotemporal patterns of seawater temperatures across the Belize Mesoamerican Barrier Reef.
Scientific data (2020) · PubMed:33199700 ↗
3 figures

Fig. 1
Map of logger deployment sites in Belize.

Fig. 2
Cross-sectional view of Carrie Bow Caye describing back reef and the two fore reefs in this area: inner fore reef and outer fore reef.
The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's Disease.
Frontiers in neurology (2020) · PubMed:33041957 ↗
6 figures

Figure 1
The role of Miro1 in mitophagy. (A) Lysosomal degradation of dysfunctional mitochondria requires the stop of mitochondrial transport and detachment from the c...

Figure 2
The role of MERCs in mitophagy and the contribution of PD-associated proteins. (A) Mitophagy also requires the untethering of impaired mitochondria from the E...
Dihuang Yinzi ameliorates post-stroke depression through Miro1 ubiquitination-dependent mitophagy.
Journal of ethnopharmacology (2026) · PubMed:41850637 ↗
No figures
Miro1 protects against brain injury after CPR in rats by enhancing the effect of BMSCs on mitochondrial homeostasis.
Stem cell research & therapy (2025) · PubMed:41153049 ↗
No figures
Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p.R450C) in the RHOT1 gene encoding Miro1.
Stem cell research (2023) · PubMed:37364399 ↗
No figures
Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1.
Stem cell research (2023) · PubMed:37003181 ↗
No figures
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
The pharmacogenomics journal (2019) · PubMed:30723313 ↗
No figures
Genome Sequence of the K139-Like Phage VcP032 Originating from the Vibrio cholerae O1 El Tor Ogawa Serotype.
Genome announcements (2016) · PubMed:27445393 ↗
No figures
📙 Related Wiki Pages (15)
NSF GenegeneNSF ProteinproteinFER GenegeneNeurodegenerationdiseaseRHOT1 Protein - MIRO1 - Mitochondrial RhproteinAlibaba Tongyi Qianwen-Bio (Chinese Biomai_toolRHOT1 - Mitochondrial Rho GTPase 1geneAmyotrophic Lateral SclerosisredirectAlzheimer's DiseasediseaseMIRO2 GenegeneBiogencompanyAmyotrophic Lateral Sclerosis (ALS)diseaseHuntington's DiseasediseaseOligodendrocytesredirectParkinson's Diseasedisease
🏥 Translation
🧬 3D Protein Structure — RHOT1
No curated PDB or AlphaFold mapping for RHOT1 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for RHOT1 from GTEx v10.
💉 Clinical Trials (5)Relevance: 38%
0
Active
Active
0
Completed
Completed
1,240
Total Enrolled
Total Enrolled
PHASE1
Highest Phase
Highest Phase
UNKNOWN·NCT04887675 · University of Novi Sad
120 enrolled · 2021-05-01 · → 2022-06-01
Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
MRI
ENROLLING_BY_INVITATION·NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
310 enrolled · 2025-02-14 · → 2026-10-01
The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
RECRUITING·NCT00029965 · National Human Genome Research Institute (NHGRI)
200 enrolled · 2002-02-06
Study description:
This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
Neurological Regression Myoclonus Cherry Red Spot
COMPLETED·NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
510 enrolled · 2020-11-16 · → 2024-12-12
The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
Retinal Function Cognitive Dysfunction Microperimetry
UNKNOWN·NCT04248270 · Chang Gung Memorial Hospital
100 enrolled · 2020-02-20 · → 2023-08-17
Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
Alzheimer's Disease Vascular Dementia Dementia
18F-PM-PBB3
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for RHOT1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
2.0 years
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 1.2%
Volatility
Medium
0.0394
Events (7d)
4
Price History
▼29.3%💾 Resource Usage
LLM Tokens
39,356
$0.2361
Total Cost
$0.2361
🔮 Predictions
🔎 Predictions vs Observations4 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If hypothesis is true, intervention provide transformative treatments for multiple neurodegenerative diseases by targeting a fundamental cellular process affected across pathological conditions | provide transformative treatments for multiple neurodegenerative diseases by targeting a fundamental cellular process affected across pathological conditions | — no observation — | pending | 0.50 |
| If hypothesis is true, intervention increase the formation and stability of these transport complexes, promoting bidirectional mitochondrial movement along microtubules | increase the formation and stability of these transport complexes, promoting bidirectional mitochondrial movement along microtubules | — no observation — | pending | 0.50 |
| If hypothesis is true, intervention facilitate therapeutic mitochondrial exchange | facilitate therapeutic mitochondrial exchange | — no observation — | pending | 0.50 |
| If hypothesis is true, intervention restore mitochondrial distribution to energy-demanding regions, improve synaptic mitochondrial content, and facilitate the formation of tunneling nanotubes and othe | restore mitochondrial distribution to energy-demanding regions, improve synaptic mitochondrial content, and facilitate the formation of tunneling nanotubes and | — no observation — | pending | 0.50 |
🔮 Falsifiable Predictions (4)
pendingconf 50%
If hypothesis is true, intervention increase the formation and stability of these transport complexes, promoting bidirectional mitochondrial movement along microtubules
Predicted outcome: increase the formation and stability of these transport complexes, promoting bidirectional mitochondrial movement along microtubules
Falsification: Intervention fails to increase the formation and stability of these transport complexes, promoting bidirectional mitochondrial movement along microtubules
pendingconf 50%
If hypothesis is true, intervention restore mitochondrial distribution to energy-demanding regions, improve synaptic mitochondrial content, and facilitate the formation of tunneling nanotubes and other intercellular conduits
Predicted outcome: restore mitochondrial distribution to energy-demanding regions, improve synaptic mitochondrial content, and facilitate the formation of tunneling nano
Falsification: Intervention fails to restore mitochondrial distribution to energy-demanding regions, improve synaptic mitochondrial content, and facilitate the formation of tunneling nanotubes and other intercellula
pendingconf 50%
If hypothesis is true, intervention facilitate therapeutic mitochondrial exchange
Predicted outcome: facilitate therapeutic mitochondrial exchange
Falsification: Intervention fails to facilitate therapeutic mitochondrial exchange
pendingconf 50%
If hypothesis is true, intervention provide transformative treatments for multiple neurodegenerative diseases by targeting a fundamental cellular process affected across pathological conditions
Predicted outcome: provide transformative treatments for multiple neurodegenerative diseases by targeting a fundamental cellular process affected across pathological con
Falsification: Intervention fails to provide transformative treatments for multiple neurodegenerative diseases by targeting a fundamental cellular process affected across pathological conditions
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.